Raltegravir 400mg tabs/PAC-60 gb

General Description:
Raltegravir 400mg film coated tablets, bottle pack of 60
(pb = patent / bottle)

Technical Specifications:
Each film-coated tablet contains 434.4 mg of Raltegravir Potassium (as salt), equivalent to 400 mg of Raltegravir.

Therapeutic class
Integrase Strand Transfer Inhibitor

Standard shelf life
2 years (24 months)

Other available formulations
The product may also be available in other formulations, pack sizes, or in combinations with other ARVs.

Guidelines for use
For more details, please see WHO treatment guidelines http://www.who.int/hiv/pub/guidelines/en/index.html and WHO Essential Medicines Library http://www.who.int/emlib/ or your regional/national guidelines.

Indications
Management of HIV-1 infection of adults in combination with other antiretroviral medicines. By mouth (oral), PO

Storage
Do not store above 30ºC
Store in tightly closed original container
Keep out of reach and sight of children.

Dispensing instructions
Dispense in original container. Do not repack

Regulatory status
For latest updates check the list of ‘Prequalified Medicines’ on the WHO website ‘Prequalification Programme’. http://apps.who.int/prequal/

For latest updates check the list of ‘USFDA approved and tentatively approved’ items on the USFDA website. http://www.fda.gov/default.htm, http://www.accessdata.fda.gov/Scripts/cder/DrugsatFDA/